Room for improvement on TIA secondary prevention

Many patients with TIA are not receiving guideline-recommended secondary prevention measures such as dual antiplatelet therapy and lipid-lowering agents, an Australian study has found. The lack of adherence to guideline recommendation was particularly noticeable for lower risk TIA patients discharged from emergency departments, an audit carried out at the Royal Brisbane and Women’s Hospital found. ...

Already a member?

Login to keep reading.

© 2021 the limbic